Q2 FY2026 Agro Chemicals Sector Analysis

Agro Chemicals Sector: Comprehensive Analysis of Key Players and Market Dynamics

The Indian agrochemical sector, a critical component of the nation's agricultural economy, is currently navigating a complex landscape characterized by evolving climatic patterns, fluctuating global demand, intense competition, and a persistent drive towards innovation and sustainability. This comprehensive analysis synthesizes data from recent investor documents and concall transcripts of five prominent players: Sumitomo Chemical India Limited, Bayer CropScience Limited, Sharda Cropchem Limited, Dhanuka Agritech Limited, and Rallis India Limited. The insights reveal a sector grappling with short-term challenges, particularly adverse weather conditions impacting domestic demand, while simultaneously positioning for long-term growth through strategic investments in R&D, backward integration, market expansion, and digital farmer engagement.

A. INDUSTRY OVERVIEW & MARKET LANDSCAPE

The agrochemical industry plays a pivotal role in enhancing agricultural productivity and ensuring food security. It encompasses a wide array of products designed to protect crops from pests, diseases, and weeds, as well as to improve soil health and plant growth. The global market is projected for steady growth, with India emerging as a significant player both in consumption and as a manufacturing and export hub.

Total Addressable Market Size and Growth Rates

The global crop protection market is estimated to grow at a Compound Annual Growth Rate (CAGR) of 3.96% from FY24 to FY33e, expanding from USD 96.1 billion to USD 141.7 billion. This indicates a robust long-term demand trajectory for agrochemical products worldwide. While specific aggregate market size for India is not provided, the growth rates of individual companies offer insights into the domestic market's vitality. Sumitomo Chemical India, for instance, reported a revenue CAGR of +13% and PAT CAGR of +20% from FY20-FY25, showcasing strong historical performance within the Indian context. Bayer CropScience, a global major with a significant Indian presence, recorded a revenue growth of 6.5% CAGR over the last five years ending FY25, primarily driven by its corn portfolio. Dhanuka Agritech also demonstrated strong growth with a +15.7% increase in revenue from FY24 to FY25. These figures suggest a healthy underlying growth in the Indian agrochemical market, often outpacing global averages in certain segments.

Market Structure and Segmentation

The agrochemical market is highly segmented by product type, application, and geographic reach.

**By Product Type:** * **Insecticides:** A dominant segment, contributing significantly to revenue for players like Sumitomo (39% of total revenue in H1 FY26) and Dhanuka (46% of Q2 FY26 revenue). * **Herbicides:** Another crucial segment, accounting for 26% of Sumitomo's H1 FY26 revenue and 54% of Sharda Cropchem's Q2 FY26 agrochemical revenue. Rallis India noted that the herbicide category is still under-indexed, indicating potential for future growth. * **Fungicides:** Representing 9% of Sumitomo's H1 FY26 revenue and 29% of Dhanuka's Q2 FY26 revenue. Sharda Cropchem's fungicide sales grew by 7% in Q2 FY26, contributing 19% to its agrochemical segment. * **Plant Growth Regulators (PGRs):** 9% of Sumitomo's H1 FY26 revenue. * **Metal Phosphides:** 8% of Sumitomo's H1 FY26 revenue. * **AND & EHD (Agro-Nutritional & Environmental Health Division):** 9% of Sumitomo's H1 FY26 revenue, with the Environmental Health division posting healthy growth. * **Seeds:** A significant segment for Bayer CropScience (corn portfolio nearly doubled in 5 years) and Rallis India (focus on cotton, maize, millet, mustard, rice, with over 80% of seed business from own research products). * **Soil and Plant Health Solutions:** Rallis India focuses on this segment, though it faced subdued demand in H1 FY26. Bio-stimulants fall under this category, facing regulatory challenges but also opportunities for organized players.

**By Segment Type:** * **Generic vs. Specialty/Branded:** * Sumitomo Chemical India's business is 70% generic and 30% specialty. Domestically, 80% is branded and 20% is bulk, while exports are 66% branded and 34% bulk. This indicates a strategic focus on branded and specialty products for higher margins. * Dhanuka Agritech emphasizes a "9(3) product" portfolio (novel chemistries) and higher contribution from specialty products for profitable growth. * Sharda Cropchem operates with a peer position in generic crop protection chemicals globally, leveraging its asset-light model and vast library of dossiers. * **Domestic vs. Export:** * Sumitomo's H1 FY26 revenue mix was 85% domestic (grew 11% YoY) and 15% export (degrew 4% YoY). * Sharda Cropchem is heavily export-oriented, with Europe contributing 58% and NAFTA 27% to its Q2 FY26 agrochemical revenue. * Rallis India saw its export revenue grow by 51% in H1 FY26, indicating a strong push into international markets to offset domestic challenges.

Key End Markets and Applications

The demand for agrochemicals is intrinsically linked to agricultural practices and crop cycles. Key crops driving demand include: * **Rice:** Lentigo (rice herbicide) and Excalia Max (fungicide for rice) are new launches for Sumitomo. Bayer is actively involved in Direct Seeded Rice (DSR) solutions, a growing application due to labor shortages and sustainability concerns. Rallis also has rice hybrids in its seed portfolio. * **Corn:** A major growth driver for Bayer CropScience, with its corn portfolio nearly doubling in the last five years and showing double-digit growth in H1 FY26. Rallis also focuses on maize seeds. * **Cotton:** Rallis India's cotton hybrid 'Diggaz' showed strong performance, though the segment faces challenges from illegal HTBt varieties and declining acreages. Herbicides for cotton suffered liquidation issues in Q2 FY26. * **Soybeans:** Herbicides for soybeans also faced liquidation issues in Q2 FY26 due to heavy rains. * **Wheat:** Rallis plans to launch a wheat herbicide. * **Mustard & Millet:** Important seed segments for Rallis India. * **Paddy:** Dhanuka launched Ipflufenoquin for transplanted paddy.

The emergence of **Direct Seeded Rice (DSR)** is a significant trend. Bayer CropScience, starting from 5,000 acres last year, is now approaching 20,000-25,000 acres, with a target of over 1 lakh acres, driven by labor shortages and sustainability benefits. This presents a new growth avenue for specialized agrochemical solutions.

Geographic Distribution and Regional Dynamics

The market exhibits distinct dynamics across different geographies: * **India (Domestic):** * **Kharif vs. Rabi:** The Indian market is heavily influenced by monsoon patterns. Kharif season typically accounts for 65% of Sumitomo's portfolio, with Rabi making up 35%. Pesticide consumption in Rabi is 30% to 40% of Kharif. * **Monsoon Impact:** Q2 FY26 (July-September 2025) witnessed abnormal and uneven rainfall. Sumitomo reported a dry spell in early July followed by continuous rain, impacting agrochemical consumption. Dhanuka and Rallis also cited excessive and uneven rainfall, leading to crop losses, delayed applications, limited pest infestation, and lower demand, resulting in revenue degrowth for both in Q2 FY26. * **Regional Variations:** Rallis noted incessant rainfall in key consuming states like Punjab, Maharashtra, UP, and Rajasthan. Dhanuka highlighted excess rainfall in some regions and deficient showers in others. * **Rabi Outlook:** Despite Q2 challenges, the outlook for the Rabi season is generally positive across companies (Sumitomo, Rallis) due to full water reservoirs, adequate soil moisture, and normal monsoon withdrawal. * **Exports:** * **Europe:** A key region for Sharda Cropchem, contributing 58% to its Q2 FY26 agrochemical revenue and being a primary driver of volume growth. * **NAFTA (North America Free Trade Agreement):** Significant for Sharda Cropchem (27% of Q2 FY26 agrochemical revenue) and a target market for exports from India. * **LATAM (Latin America):** Sumitomo saw a 33% YoY decline in sales to South America in H1 FY26 due to shipment deferrals, but expects recovery in H2. Sharda Cropchem's LATAM sales grew 21% in Q2 FY26, contributing 9%. Rallis sees strong export demand from Brazil. * **Africa & Southeast Asia:** Sumitomo is broadening its footprint in these regions, expecting Africa to be on track for H2. * **Asia & Middle East:** Sumitomo is expanding registrations and customer relationships here. * **Global Stabilization:** The global agrochemical industry is showing early signs of stabilization after two years of inventory destocking, pricing pressure, and climate disruptions, according to Sumitomo and Rallis. This bodes well for export-oriented players.

Market Maturity and Lifecycle Stage

The global agrochemical industry appears to be in a **mature but evolving stage**. After a period of inventory destocking and pricing pressure in the last two years, there are "early signs of stabilization" and "gradual demand improvement" globally, as noted by Sumitomo and Rallis. This suggests a recovery phase is underway. In India, the market is characterized by a mix of mature generic products and a growing emphasis on specialty, innovative, and differentiated solutions. The increasing focus on R&D, new product launches, and digital farmer engagement indicates a drive towards higher value-added segments and improved market penetration. The shift towards sustainable practices and solutions like DSR also points to an evolving market landscape.

Industry Value Chain and Ecosystem

The agrochemical value chain is comprehensive, involving several stages: 1. **Research & Development (R&D):** Companies like Sumitomo (3 R&D labs, 75+ scientists, 25+ patents), Dhanuka (2 NABL accredited R&D labs, 30 chemists), and Rallis (RICH, Ag-Biotech Centre, INR 60-70 Cr annual budget) are heavily investing in developing new molecules, formulations, and breeding technologies. India is even identified as a #1 category for testing new molecules by Sumitomo Chemical Japan. 2. **Manufacturing:** This includes the production of Technical Actives (AIs) and formulations. * **In-house Manufacturing:** Sumitomo (5 facilities, 14 Technical Actives), Dhanuka (4 units, synthesis plant at Dahej), Rallis (5 owned facilities, multi-purpose plants at Dahej). Companies are increasingly focusing on backward integration (Sumitomo at Tarapur, Dahej; Bayer sourcing more in India). * **Outsourced Manufacturing:** Sharda Cropchem operates an asset-light model, outsourcing manufacturing of AIs and formulations, focusing on identifying generic molecules and registrations. Rallis also uses 9 third-party facilities. 3. **Distribution & Sales:** An extensive network is crucial for reaching farmers. * **Direct Distribution:** Sumitomo has 15,000+ direct distributors and 60 depots. * **Dealer/Retailer Network:** Dhanuka boasts 6,500+ distributors and 80,000+ retailers. Rallis has 6,600 dealers and 95,000 retailers. Sharda Cropchem uses 525 third-party distributors and 500+ sales force globally. * **Farmer Connect:** Companies are investing heavily in direct farmer engagement through physical meetings (Sumitomo: 4.4 million+ farmer connect, 1,500+ relationship managers; Dhanuka: 26,469 farmers enrolled, 18,476 trained in Q2 FY26; Rallis: 8 million+ farmer connects) and digital initiatives (Sumitomo: 20 million+ digital connect; Dhanuka: extensive social media reach; Rallis: leveraging digitalization). 4. **Post-Sales Support & Education:** Training programs, field days, and village meetings (Dhanuka) are integral to ensuring proper product usage and maximizing farmer yields.

The ecosystem also includes collaborations with global innovators (Dhanuka, Sumitomo, Bayer, Rallis), agriculture universities, and Krishi Vigyan Kendras (KVKs) (Dhanuka) to drive research, product development, and farmer outreach.

B. FINANCIAL & ECONOMIC PROFILE

The financial performance of the agrochemical sector in H1 FY26 presents a mixed picture, reflecting the impact of adverse climatic conditions on domestic demand, coupled with varying success in export markets and strategic shifts towards higher-margin products.

Industry Aggregate Revenue Scale and Growth Trajectory

While a precise industry aggregate is not available, combining the reported revenues of the five companies provides a snapshot of their collective scale and recent growth.

**Q2 FY26 (Ended 30th September 2025) Revenue Performance:** * **Sharda Cropchem:** INR 929.1 Cr (+20% YoY) - **Strong Growth** * **Sumitomo Chemical India:** INR 930 Cr (-6% YoY) - **Decline** * **Rallis India:** INR 861 Cr (-7% YoY) - **Decline** * **Dhanuka Agritech:** INR 598.25 Cr (-8.56% YoY) - **Decline** * **Bayer CropScience:** (Q2 specific revenue not provided, H1 sales +3%)

The Q2 FY26 performance was significantly impacted by the adverse monsoon, leading to revenue degrowth for three out of four companies that provided Q2 figures. Sharda Cropchem, with its strong export focus, was a notable outlier, achieving robust growth.

**H1 FY26 (Ended 30th September 2025) Revenue Performance:** * **Sumitomo Chemical India:** INR 1,987 crores (+9% YoY) - **Healthy Growth** * **Sharda Cropchem:** INR 1,913.9 crores (+23% YoY) - **Exceptional Growth** * **Rallis India:** INR 1,818 crores (+6.2% YoY) - **Moderate Growth** * **Bayer CropScience:** Sales grew 3% YoY - **Modest Growth** * **Dhanuka Agritech:** (H1 specific revenue not provided, Q2 was negative, FY25 was +15.7%)

For H1 FY26, the picture is more positive, with most companies showing growth, indicating resilience and recovery from Q2 challenges or strong performance in other segments (like exports). Sharda Cropchem's 23% growth in H1 FY26 stands out, primarily driven by higher volume growth of 24%. Sumitomo also achieved a reasonable 9% growth in H1 despite a challenging Q2.

**Historical Growth Trajectory (FY20-FY25):** * **Sumitomo Chemical India:** Revenue CAGR of +13% (FY20-FY25). * **Bayer CropScience:** Revenue growth of 6.5% CAGR over the last 5 years (ending FY25), with its corn portfolio nearly doubling (15-16% CAGR). * **Dhanuka Agritech:** Revenue from Operations of INR 2035.15 Crores in FY25, a +15.7% increase from INR 1758.54 Crores in FY24. * **Sharda Cropchem:** Revenue of INR 4,320 Cr in FY25.

These historical figures demonstrate a generally robust growth trajectory for the sector, driven by increasing agricultural demand and product innovation.

Profitability Levels Across Companies

Profitability metrics like Gross Margin, EBITDA Margin, and PAT Margin show variations, reflecting different business models, product mixes (specialty vs. generic), and operational efficiencies.

**Q2 FY26 Profitability:** | Company | Gross Profit Margin (%) | EBITDA Margin (%) | PAT Margin (%) | | :----------------------- | :---------------------- | :---------------- | :------------- | | Sumitomo Chemical India | 43.1% | 23.4% | 19.1% | | Dhanuka Agritech | 42.45% | 22.85% | 15.71% | | Sharda Cropchem | 34.5% | 15.0% | 8.0% | | Rallis India | (Not explicitly stated) | 17.9% | 11.8% |

**H1 FY26 Profitability:** | Company | Gross Profit Margin (%) | EBITDA Margin (%) | PAT Margin (%) | | :----------------------- | :---------------------- | :---------------- | :------------- | | Sumitomo Chemical India | 40.4% | 22.0% | 17.9% | | Sharda Cropchem | 35.0% | 14.7% | 11.3% | | Bayer CropScience | >100 bps expansion | (Not stated) | (Not stated) |

**FY25 Profitability:** | Company | Gross Profit Margin (%) | EBITDA Margin (%) | PAT Margin (%) | | :----------------------- | :---------------------- | :---------------- | :------------- | | Dhanuka Agritech | 40.10% | 20.47% | 14.59% | | Sharda Cropchem | (Not stated) | 15.8% | 7.0% |

**Range of Margins with Median and Outliers:** * **Gross Profit Margin:** Ranges from 34.5% (Sharda Q2 FY26) to 43.1% (Sumitomo Q2 FY26). Sumitomo and Dhanuka consistently exhibit higher gross margins, likely due to their stronger focus on branded and specialty products, and in-house manufacturing capabilities. Sharda, with its asset-light, generic-focused export model, operates at a slightly lower gross margin but has shown significant improvement (34.5% in Q2 FY26 vs 27.6% in Q2 FY25). * **EBITDA Margin:** Ranges from 14.7% (Sharda H1 FY26) to 23.4% (Sumitomo Q2 FY26). Again, Sumitomo and Dhanuka lead in EBITDA margins, reflecting their ability to control operational costs relative to their revenue and gross profit. Sharda showed remarkable EBITDA margin expansion (15.0% in Q2 FY26 vs 10.5% in Q2 FY25), indicating improved operational efficiencies and pricing. Rallis's Q2 EBITDA margin was 17.9%. * **PAT Margin:** Ranges from 8.0% (Sharda Q2 FY26) to 19.1% (Sumitomo Q2 FY26). Sumitomo maintains the highest PAT margins, followed by Dhanuka. Sharda's PAT margin also saw substantial improvement (8.0% in Q2 FY26 vs 5.5% in Q2 FY25). Rallis's Q2 PAT margin was 11.8%.

**Key Observations on Profitability:** * **Margin Expansion:** Sharda Cropchem demonstrated significant margin expansion across all profitability metrics in Q2 and H1 FY26, driven by lower input costs and improved price realizations. Bayer also reported over 100 basis point expansion in Gross Margin for H1 FY26. * **Margin Pressure:** Dhanuka Agritech experienced a decline in EBITDA and PAT margins in Q2 FY26 due to lower demand. Rallis India's EBITDA margin remained flat YoY in Q2 FY26, though PAT margin improved due to other factors. * **Management Focus:** Companies like Sumitomo prioritize maintaining or improving EBITDA and PBT margins. Bayer aims for 100 basis points improvement in Gross Margin for the next two to three years.

Return Profiles (ROCE, ROE) by Company

Return ratios indicate how efficiently companies are using capital to generate profits. * **Sumitomo Chemical India:** Reported a strong **ROCE of 29.0% for FY25**, highlighting its capital efficiency and profitability. * **Sharda Cropchem:** Achieved a **ROCE of 21.6%** and **RoE of 17.5%** on a TTM basis as of 30th September 2025. These are healthy returns, especially considering its asset-light model. Its FY25 ROCE was 16.0% and RoE was 12.8%, indicating significant improvement in the first half of FY26.

These figures suggest that leading players in the sector are generating attractive returns on the capital employed, which is crucial for long-term value creation.

Working Capital Characteristics and Cash Conversion Cycles

Efficient working capital management is vital in an industry with seasonal demand and long supply chains. * **Sumitomo Chemical India:** Demonstrated significant improvement in working capital efficacy. Its **Net Working Capital Days improved by 7 days YoY to 55 days in H1 FY26** (from 62 days in Sep-24 and 89 days in Mar-25). This indicates strong liquidity management and prudent deployment of working capital. The company also boasts substantial cash and cash equivalents of INR 2,089 crores as of 30th September 2025, reflecting its strong balance sheet flexibility. * **Sharda Cropchem:** Also showed impressive improvement, reducing its **Working Capital Days by 34 days from March 2025 to 84 days as of 30th September 2025**. This was driven by Inventory Days of 93, Receivable Days of 96, and Creditor Days of 88. The company also holds a healthy cash, bank & liquid investments balance of INR 794 crores (vs INR 558 crores on Mar'25). * **Bayer CropScience:** Emphasizes vigilant cash management, having learned from receivables issues in the previous year (FY25). * **Rallis India:** Reported cash and liquid balance of INR 454 crores as of 30th September 2025.

The focus on improving working capital days and maintaining strong cash balances across companies underscores the importance of financial discipline in navigating market volatilities and funding growth initiatives.

Capital Intensity Requirements

The agrochemical sector can be capital-intensive, especially for companies engaged in in-house manufacturing and backward integration. * **Sumitomo Chemical India:** Has significant capex plans, including **INR 500 crores to INR 600 crores over the next 5 years for 7 products at its Dahej greenfield expansion**. Additionally, it plans **INR 8 crores to INR 10 crores investment at Tarapur** to manufacture Excalia Max for Indian requirements by March 2027. This indicates a substantial investment in expanding manufacturing capabilities and backward integration. * **Sharda Cropchem:** Incurred **CAPEX of Rs. 250 Cr in H1 FY26**, reflecting its investment in growth, despite its asset-light model for manufacturing. * **Rallis India:** Envisages **capex spends of around INR 50 crores**, which appears more focused on maintenance or smaller expansions compared to Sumitomo. * **Dhanuka Agritech:** Has a synthesis plant at Dahej and is starting trial production of a second product, implying ongoing capital investments in manufacturing.

These capex figures highlight varying strategies: some companies (Sumitomo, Dhanuka) are investing heavily in expanding their manufacturing footprint and backward integration, while others (Sharda) maintain an asset-light model but still invest in growth-enabling infrastructure or registrations.

Revenue Quality (Recurring vs One-time, Contract Length)

The revenue in the agrochemical sector is generally recurring, driven by annual crop cycles and the continuous need for crop protection. However, the exact nature of contracts (e.g., long-term supply agreements vs. spot sales) is not explicitly detailed for all companies. * **Branded vs. Bulk:** Companies with a higher proportion of branded products (e.g., Sumitomo's 80% domestic branded, Dhanuka's focus on 9(3) products) likely enjoy more stable demand and better pricing power, contributing to higher revenue quality. * **New Product Launches:** While new products contribute to growth (8-10% for Sumitomo annually), their initial sales might be considered "one-time" in terms of launch impact, but they quickly integrate into the recurring revenue stream as they gain market acceptance. * **Export Contracts:** Export revenues can be subject to global inventory cycles and shipment deferrals (as seen with Sumitomo in LATAM), which can introduce some volatility. However, long-term relationships with global players (Rallis, Sharda) aim to stabilize these revenues.

Overall, the sector's revenue is largely recurring, tied to the fundamental and continuous demand for food production, making it relatively stable over the long term, albeit with seasonal and climatic fluctuations.

C. COMPETITIVE STRUCTURE & DYNAMICS

The agrochemical sector is characterized by a mix of large multinational corporations, established Indian players, and numerous smaller regional entities. The competitive landscape is dynamic, influenced by innovation, pricing, distribution reach, and regulatory environments.

Number of Players and Market Concentration

The presence of global giants like Bayer CropScience alongside strong Indian players such as Sumitomo Chemical India, Dhanuka Agritech, Rallis India, and Sharda Cropchem indicates a moderately fragmented market. While specific market share percentages are not provided for all players, the reported revenues suggest that these five companies are significant contributors to the organized segment of the Indian agrochemical market. Bayer, being a global leader, holds a strong position, particularly in segments like corn seeds and certain crop protection chemicals. Sumitomo Chemical India, with its parent company's global backing, is also a formidable player, especially with its focus on specialty products and backward integration. Sharda Cropchem's global reach and asset-light model position it as a strong competitor in the generic export market.

Market Share Distribution (with specific percentages)

Specific market share percentages for the overall Indian agrochemical market are not provided in the extracts. However, some insights into segment leadership are available: * **Bayer CropScience:** A main breeder for corn in India, with its corn portfolio nearly doubling in the last 5 years, suggesting a leading position in this segment. Its Council Activ product (launched FY22-23) is already among the top two/three products, indicating strong market penetration for new launches. * **Sumitomo Chemical India:** Possesses a reputation as a trusted provider of high efficacy solutions and has 20+ mega brands, implying a strong brand presence and market share in various product categories. * **Rallis India:** Its cotton hybrid 'Diggaz' has shown strong performance, and more than 80% of its seed business comes from its own research products, indicating a significant presence in the seeds segment.

Competitive Intensity Assessment (Porter's 5 Forces style)

1. **Threat of New Entrants (Moderate to High):** * **Barriers to Entry:** High R&D costs for new molecule discovery, extensive regulatory approval processes (registrations, patents), need for a robust distribution network, and significant capital investment for manufacturing facilities. Companies like Sumitomo (25+ patents, 200+ registrations) and Sharda (2,994 registrations procured, 1,068 pending) highlight the importance of intellectual property and regulatory hurdles. * **Mitigation:** Global tie-ups (Dhanuka, Sumitomo, Bayer, Rallis) allow access to novel chemistries without the full R&D burden. Asset-light models (Sharda) can lower capital intensity. 2. **Bargaining Power of Buyers (Moderate to High):** * **Farmers:** Price sensitivity, especially for generic products. Impact of weather conditions directly affects demand and purchasing power. * **Distributors/Retailers:** Companies rely on extensive networks, giving distributors some leverage. However, strong brand equity (Sumitomo, Bayer) and farmer connect programs can mitigate this. * **Global Customers (for exports):** Can defer shipments (Sumitomo in LATAM) and exert pricing pressure (Rallis). 3. **Bargaining Power of Suppliers (Moderate):** * **Raw Material Suppliers:** Volatility in input prices (Bayer noted stabilization in H1 FY26). Dependence on China for certain raw materials. * **Mitigation:** Backward integration (Sumitomo, Bayer, Dhanuka) and diversified sourcing arrangements (Sharda) reduce reliance on external suppliers and improve cost control. 4. **Threat of Substitute Products or Services (Moderate):** * **Biologicals/Bio-stimulants:** While currently a smaller segment, there's a growing interest in biological solutions. Regulatory changes (Sumitomo, Rallis) are shaping this market. * **Integrated Pest Management (IPM):** Farmers adopting non-chemical methods. * **Illegal Varieties:** Widespread adoption of illegal HTBt cotton varieties (Rallis) poses a significant threat to organized seed companies. 5. **Rivalry Among Existing Competitors (High):** * **Pricing Pressure:** Intense competition, especially in generic segments, leading to pricing pressure (Sumitomo competes with Chinese prices, Rallis expects subdued domestic pricing). * **Innovation Race:** Constant launches of new products (all companies) to gain market share and differentiate. * **Distribution & Farmer Outreach:** Companies are aggressively expanding their reach and engagement programs. * **China Competition:** A recurring theme, impacting pricing and export competitiveness (Sumitomo, Bayer, Rallis).

Entry Barriers and Competitive Moats

• **R&D and IP:** Developing new molecules and securing registrations/patents is a significant barrier. Sumitomo (25+ patents), Sharda (2,994 registrations), and Dhanuka (300+ registrations, focus on 9(3) products) highlight this.
• **Brand Equity & Trust:** A strong reputation for efficacy and sustainability (Sumitomo) builds farmer loyalty.
• **Extensive Distribution Network:** Reaching millions of farmers across diverse geographies requires a vast and efficient network (Dhanuka: 6,500+ distributors, 80,000+ retailers; Rallis: 6,600 dealers, 95,000 retailers).
• **Manufacturing Capabilities & Backward Integration:** In-house production of technicals (Sumitomo, Dhanuka, Rallis) provides cost advantages and supply security.
• **Global Tie-ups:** Collaborations with international innovators (Dhanuka with Nisso Chemicals, Japan; Sumitomo with its parent; Bayer's global pipeline) provide access to advanced technologies and products.
• **Farmer Connect & Digitalization:** Direct engagement and digital platforms create stickiness and improve market intelligence.

Pricing Power Dynamics and Pricing Trends

• **Mixed Trends:** Pricing power varies by segment and market.

Differentiation Strategies Employed

• **Innovation-led Growth:** All companies emphasize new product launches and R&D pipelines.
• **Portfolio Mix:**
• **Backward Integration & Sourcing:**
• **Farmer Engagement & Digitalization:**
• **Global Footprint & Supply Chain Integration:**
• **Asset-Light Model:** Sharda Cropchem's strategy of outsourcing manufacturing allows it to focus on core competencies of registrations and distribution, offering flexibility and cost competitiveness.

Consolidation Trends and M&A Activity

The provided data does not explicitly mention significant consolidation trends or M&A activity within the Indian agrochemical sector. However, the strategic alliances and global tie-ups (e.g., Dhanuka with Nisso, Sumitomo's integration with its parent) can be seen as a form of strategic collaboration that might preclude outright M&A for certain product lines or technologies.

Competitive Advantages of Each Player

• **Sumitomo Chemical India:**
• **Bayer CropScience Limited:**
• **Sharda Cropchem Limited:**
• **Dhanuka Agritech Limited:**
• **Rallis India Limited:**

D. OPERATIONAL CHARACTERISTICS

Operational efficiency, capacity utilization, and supply chain management are critical for success in the agrochemical industry, directly impacting cost structures and responsiveness to market demand.

Capacity and Utilization Trends Across Companies

• **Sumitomo Chemical India:** Reported **technical plants operating at 85% to 90% capacity utilization**. This indicates efficient use of existing assets and room for some organic growth without immediate major capex, though significant expansion plans are underway (Dahej, Tarapur). The company sold 3,000 tonnes of Mera 71 in H1 FY26, its highest ever for an entire year, demonstrating strong product-specific demand and capacity utilization.
• **Dhanuka Agritech:** Operates 4 manufacturing units, including a synthesis plant at Dahej, which has started trial production of a second product. Sales of Bifenthrin from Dahej are on track. This suggests ongoing efforts to bring new capacities online and utilize them effectively.
• **Rallis India:** Has 5 owned manufacturing facilities (Akola, Lote, Ankaleshwar, Multi-purpose plants at Dahej CZ & Dahej SEZ) and 9 third-party facilities. The company commercialized planned capacity expansion with new efficient technologies, indicating a focus on enhancing production capabilities. Exports are a key focus for maximizing volume and driving capacity utilization.
• **Sharda Cropchem:** Employs an asset-light business model, outsourcing manufacturing of AIs and formulations. This means its operational characteristics are more focused on supply chain management and quality control with its manufacturing partners rather than in-house capacity utilization.

Overall, companies with in-house manufacturing are generally operating at high utilization rates, indicating healthy demand for their products and efficient production planning.

Production Economics and Cost Structures

• **Input Costs:** The industry is sensitive to raw material prices. Bayer CropScience noted a **stabilization in input prices in H1 FY26**, which is a positive development after previous pressures. Sharda Cropchem benefited from **lower input costs** in FY26, contributing significantly to its margin expansion. Conversely, Bayer mentioned a "squeeze on production costs, high energy and environmental costs in Europe" as a challenge.
• **Backward Integration:** Companies like Sumitomo and Bayer are pursuing backward integration to gain better control over costs, quality, and supply security for key molecules. Sumitomo has commenced backward integration for selected molecules at its Tarapur facility and plans to produce Sumitomo origin molecules and intermediates at Dahej. Bayer is backward integrated for larger compounds in India. This strategy aims to improve production economics by reducing reliance on external suppliers and potentially achieving economies of scale.
• **Operational Efficiencies:** Sharda Cropchem's focus on "operational efficiencies," "better cost management," and eliminating "NVAs" (Non-Value Added activities) contributed to its margin improvements. Bayer also implemented OPEX reduction strategies, including reducing management layers.
• **Cost Competitiveness:** Sumitomo claims to be able to compete with Chinese prices in generic products due to R&D and process improvements, highlighting a focus on cost-effective production. Rallis also lists "Focus on Cost Competitiveness" as a long-term strategy.

Supply Chain Structure and Dependencies

The supply chain in agrochemicals is global and complex, with dependencies on various regions for raw materials and intermediates. * **Global Sourcing:** Bayer CropScience is on a path to **sourcing more in Asia, more in India** (from own plants or partners), aiming for a 50-50 situation for India/Asia sourcing vs. global sourcing for CP raw materials. This indicates a strategic shift towards regionalizing supply chains. * **Diversified Sourcing:** Sharda Cropchem emphasizes "diversified sourcing arrangements" and "enduring relationships with multiple manufacturers and formulators," which is crucial for its asset-light model to mitigate supply risks. * **Parent Company Integration:** Sumitomo Chemical India is increasing integration with its parent company's global supply chain and registration network, leveraging a global sourcing and distribution advantage. * **Supply Chain Constraints:** Rallis India faced "significant supply chain constraints for maize" in Q2 FY26, particularly in Tamil Nadu and neighboring states, which impacted its seed business. This highlights the vulnerability of even well-established supply chains to regional disruptions. * **Geopolitical Impact:** Rallis noted that suppliers are looking for alternate sources like India due to the geopolitical situation, presenting an opportunity for Indian manufacturers to become more prominent in the global supply chain.

Technology Landscape and Innovation Pace

The industry is driven by continuous innovation, from new molecule discovery to advanced breeding techniques and digital farming solutions. * **R&D Investment:** Companies are investing significantly in R&D. Sumitomo has 3 DSIR approved R&D labs and 75+ scientists. Dhanuka has 2 NABL accredited R&D labs and 30 chemists. Rallis has Rallis Innovation Chemistry Hub (RICH) and an Ag-Biotech Centre, with an annual R&D budget of INR 60-70 crores. * **New Molecule Development:** Sumitomo Chemical Japan identifies India as a #1 category for testing new molecules, and Sumitomo India has received 2 such molecules for testing. Dhanuka focuses on novel chemistries and "9(3) product" portfolio. * **Modern Breeding Tools:** Rallis is focusing on modern breeding tools (biotechnology driven, not GM crops) for its seed business. * **Digitalization:** All companies are leveraging digital technologies for farmer connect, market reach, and operational efficiency. Sumitomo has 20 million+ digital connect. Dhanuka uses YouTube, Instagram, LinkedIn, Facebook for digital reach. Rallis is building an "Information Highway for Demand Fulfilment and Demand Creation" and focusing on a "Digital / Data Driven Organization Culture." * **Formulation & AI Development:** Companies are developing a wide range of formulations and active ingredients (AIs). Sharda offers a wide range of formulations and AIs.

Operational Efficiency Benchmarks

• **Working Capital Days:** As discussed, Sumitomo (55 days in H1 FY26) and Sharda (84 days in Sep-25) are actively improving their working capital cycles, indicating strong operational efficiency in managing inventory, receivables, and payables.
• **Capacity Utilization:** Sumitomo's 85-90% technical plant utilization is a good benchmark for efficient asset use.
• **Margin Improvement:** Sharda's significant gross and EBITDA margin expansion (e.g., EBITDA margin from 10.5% to 15.0% in Q2 FY26) demonstrates successful operational efficiency initiatives. Bayer's 100 bps gross margin expansion also points to improved efficiency.

Key Performance Indicators (Company-specific and Industry Averages)

• **Innovation Turnover Index (Dhanuka Agritech):** This metric tracks new molecules as a percentage of total revenue, showing a consistent upward trend: 9.05% (FY22), 12.75% (FY23), 13.29% (FY24), 14.93% (FY25), 16.14% (H1 FY26). This highlights Dhanuka's success in driving growth through new product introductions.
• **Farmer Connect & Digital Reach:** Metrics like millions of farmer connects (Sumitomo, Rallis) and digital views/followers (Dhanuka) are crucial KPIs for market penetration and brand building.
• **New Product Contribution:** Sumitomo states new products contribute 8% to 10% on a yearly basis, indicating a healthy pipeline. Rallis's new products (Deeweed, Dodrio) more than doubled volume YTD.
• **Seed Business Performance:** Rallis measures the proportion of its seed business from own research products (over 80% in H1 FY26) and targets an EBITDA margin of 23-25% for this segment. Bayer tracks corn portfolio growth (double-digit in H1 FY26).
• **Export Growth:** Rallis's 51% export growth in H1 FY26 and Sharda's 27% NAFTA growth in Q2 FY26 are key indicators of international market success.

Asset Efficiency Metrics

• **ROCE (Return on Capital Employed):** Sumitomo's 29.0% (FY25) and Sharda's 21.6% (TTM Sep-25) are strong indicators of how effectively these companies are using their capital to generate profits. Sharda's improvement from 16.0% in FY25 to 21.6% in TTM Sep-25 is particularly noteworthy.
• **ROIC (Return on Invested Capital):** Not explicitly provided, but ROCE serves as a good proxy.
• **Revenue per Employee:** Not provided, but the number of employees (Sumitomo: 1600+) and sales force (Sharda: 500+ globally) relative to revenue can give an indirect sense of labor efficiency.

E. GROWTH DYNAMICS & DRIVERS

The agrochemical sector's growth is propelled by a combination of historical momentum, current market conditions, and strategic initiatives focused on innovation, market expansion, and farmer engagement.

Historical Growth Trajectory (3-5 year view with specific rates)

• **Sumitomo Chemical India (FY20-FY25):**
• **Bayer CropScience Limited (Last 5 years ending FY25):**
• **Dhanuka Agritech Limited (FY24-FY25):**

Current Growth Rates and Acceleration/Deceleration

• **H1 FY26 Performance:**

The H1 FY26 period shows a mixed picture. While some companies like Sharda and Sumitomo maintained healthy growth, others like Dhanuka and Rallis faced headwinds in Q2 due to climatic conditions, leading to short-term deceleration in domestic markets. However, strong export performance (Sharda, Rallis) and specific segment growth (Bayer's corn) provided resilience.

Volume vs Price Contribution to Growth

• **Sharda Cropchem:** H1 FY26 revenue increase of 23% was primarily driven by **higher volume growth of 24%**. This indicates strong market acceptance and demand for its products.
• **Rallis India:** Q2 FY26 revenue degrowth of 7% was attributed to **6% volume degrowth and 1% price degrowth**. This highlights the impact of reduced demand and some pricing pressure.
• **Bayer CropScience:** Took a **nearly double-digit price increase for Dekalb corn products** in H1 FY26, suggesting that price contributed positively to its corn sales growth.
• **Sumitomo Chemical India:** Maintained "disciplined pricing practices" and aims to "maintain price line even if volumes go up," indicating a focus on value over aggressive price cuts.

The balance between volume and price contribution is dynamic. While volume growth is a primary driver, strategic pricing and cost management are crucial for margin expansion.

Organic vs Inorganic Growth Components

The provided data primarily highlights **organic growth** strategies: * **New Product Launches:** All companies are actively launching new products from their R&D pipelines or through global collaborations. * **Market Penetration:** Expanding distribution networks, increasing farmer connect, and entering new geographies. * **Capacity Expansion:** Investments in manufacturing facilities to support increased production.

There is no explicit mention of significant inorganic growth (M&A) activities in the provided extracts.

Geographic Expansion Opportunities and Progress

• **Sumitomo Chemical India:** Actively enhancing exports competitiveness and global footprint by broadening presence across **Africa, Latin America, and Southeast Asia**. India is positioned as a critical manufacturing and export base for the parent company.
• **Sharda Cropchem Limited:** Consistently increasing global presence with business operations in **80+ countries (Europe, NAFTA, Latin America, and RoW)**. Europe is a key contributor to its volume growth. The company aims to further penetrate existing markets and enter new ones using its library of dossiers.
• **Rallis India Limited:** Focused on expanding its **export business**, which grew by 51% in H1 FY26. It is expanding its customer base and securing registrations with more global players for technicals.
• **Bayer CropScience Limited:** Its broad portfolio allows entry into new geographies within India.

These efforts indicate a strong drive among Indian agrochemical companies to diversify their revenue streams geographically and capitalize on global demand.

Product/Service Innovation Pipeline

Innovation is a core growth driver for all players. * **Sumitomo Chemical India:** Scaling up recently launched products like **Lentigo (rice herbicide)** and patented fungicide **Excalia Max (INDIFLIN technical product)**, both well-received pan-India. Planning to launch **Top Grain** (from Valent BioSciences) in H2 FY26. New products contribute 8-10% of yearly revenue. * **Bayer CropScience Limited:** Strong R&D pipeline with new launches like **Bicota (fungicide), Camalus (fungicide), Etcio Star (for DSR portfolio), Xivana Smart (fruit and vegetable segment, expected early next year), and Plenexos (global blockbuster insecticide, next couple of years)**. Almost one-sixth of last year's CP sales came from products launched in the last three years. * **Dhanuka Agritech Limited:** Focus on margin-accretive "9(3) product" portfolio. Introduced **Ipflufenoquin** (in collaboration with Nisso Chemicals, Japan) for indigenous manufacture. Targets launching several new products across all segments over the next two years. Innovation Turnover Index shows increasing contribution from new molecules. * **Rallis India Limited:** Launched 8 new products YTD in FY26, including **Deeweed (herbicide) and Dodrio (fungicide)**, which have more than doubled volume YTD. Upcoming launches include a wheat herbicide and a rice herbicide (completely 9(3)). Focused on accelerating the launch pipeline for proprietary research added varieties in seeds.

The continuous introduction of new, differentiated, and often patented products is crucial for maintaining competitive edge and driving premiumization.

Adjacent Market Opportunities

• **Direct Seeded Rice (DSR):** A significant opportunity identified by Bayer CropScience, driven by labor shortages and sustainability benefits. Bayer's DSR acreage grew from 5,000 to 20,000-25,000 acres, targeting over 1 lakh.
• **Bio-stimulants/Soil & Plant Health:** Rallis India has a dedicated focus on Soil and Plant Health, though it faced subdued demand in H1 FY26. Regulatory changes in bio-stimulants are seen as positive for organized market players. Sumitomo's Barrix Agro Sciences (biostimulant) is sufficiently equipped for current year capacity.
• **Environmental Health Division (EHD):** Sumitomo's EHD posted healthy growth, indicating potential beyond traditional crop protection.
• **Semiconductor Business:** Sumitomo is actively monitoring opportunities in India's semiconductor sector, though this is a diversification beyond agrochemicals.
• **Display, Pharma:** Sumitomo is also evaluating opportunities in these segments in India.

These adjacent markets offer diversification and new avenues for growth, leveraging existing R&D and manufacturing capabilities.

Customer Acquisition and Penetration Trends

Companies are employing multi-pronged strategies to acquire and retain farmers: * **Extensive Farmer Connect Programs:** * Sumitomo: 'Every Day Farmers Day' (EDFD) initiative, 4.4 million+ farmer connect through physical meetings, 1,500+ relationship managers. * Dhanuka: Dhanuka Krishi Mitra Meetings, Field Days, Village Meetings, individual connections (26,469 farmers enrolled, 18,476 trained in Q2 FY26). * Rallis: 8 million+ farmer connects, 1,800 Seed villages, 28,000 Growers. * **Digital Engagement:** * Sumitomo: 20 million+ Digital Connect. * Dhanuka: Significant presence on YouTube, Instagram, LinkedIn, Facebook (e.g., 100 L YouTube views, 1262 L Instagram/Facebook reach in Q2 FY26). * Rallis: Leveraging digitalization for demand creation. * **Partnerships:** Bayer's "Better Life Farming" is a partner-based retail ecosystem, helping service farmers profitably, especially in the East of the country. Dhanuka strengthens associations with Agriculture Universities and KVKs. * **Geographical Expansion:** Expanding distribution networks to cover more states and districts (Sumitomo covers 26 states, Rallis covers 80% of India's districts).

These efforts aim to deepen penetration, build brand loyalty, and ensure effective product adoption among the vast smallholder farmer base in India.

F. RISK LANDSCAPE

The agrochemical sector is exposed to a range of risks, from environmental and climatic factors to competitive pressures, regulatory changes, and global economic uncertainties.

Industry-wide Systematic Risks

• **Climatic Conditions and Monsoon Volatility:** This is the most significant and frequently cited risk.
• **Commodity Prices:** Commodity prices (except paddy/rice) remained under pressure (Bayer), which can affect farmer income and their ability to purchase agrochemicals.
• **Global Inventory Destocking:** The global agrochemical industry has witnessed two years of inventory destocking (Sumitomo, Rallis), which can impact export demand and pricing.
• **Geopolitical Situation:** Suppliers looking for alternate sources like India due to geopolitical situation (Rallis) can be an opportunity but also indicates underlying global instability.

Cyclicality and Economic Sensitivity

• **Agricultural Cycles:** The industry is inherently cyclical, tied to agricultural seasons (Kharif, Rabi) and crop cycles.
• **Rural Economy:** Performance is sensitive to the health of the rural economy, farmer income, and government support for agriculture. Healthy rural sentiment is a growth driver (Sumitomo).
• **Global Economic Slowdown:** Muted export demand in certain geographies (Sumitomo in Africa, LATAM) can be linked to broader economic conditions.

Regulatory and Policy Risks by Geography

• **Biostimulant Regulations:** Sales of biostimulants (Barrix Agro Sciences for Sumitomo, Rallis's biofertilizer business) were affected by regulatory constraints. However, regulatory changes are also seen as positive for organized market players in the long run (Rallis).
• **GMO Policy:** Speculation on corn imports from the US (GMO corn) and policy reconsideration for Indian farmers' access to technology (GMO) are risks/opportunities for Bayer. Widespread adoption of illegal HTBt varieties (Rallis) highlights a regulatory enforcement challenge.
• **Tariff Situation:** US tariffs on Chinese agrochemical imports (up to 60%) can create opportunities for Indian exporters but also introduce uncertainty for global trade (Sumitomo, Rallis).

Technology Disruption Threats

• **Illegal Varieties:** The widespread adoption of illegal HTBt cotton varieties significantly impacted organized seed companies like Rallis, leading to higher returns and reduced sales. This is a major threat to intellectual property and market integrity.
• **New Technologies:** While companies are investing in R&D, rapid advancements in biotechnology or alternative pest control methods could disrupt existing product lines.

ESG and Sustainability Challenges

• **Environmental Costs:** High energy and environmental costs in Europe (Bayer) indicate increasing pressure for sustainable production practices globally.
• **Sustainable Solutions:** The drive towards sustainability also presents an opportunity for companies offering eco-friendly products and practices (e.g., DSR solutions).

Supply Chain Vulnerabilities

• **Raw Material Sourcing:** Dependence on specific regions (e.g., China) for raw materials can lead to supply disruptions and price volatility.
• **Logistics & Distribution:** Supply chain constraints for specific products (Rallis for maize seeds) can impact market availability and sales.
• **Receivables Issues:** Bayer faced issues with receivables in FY25, highlighting the risk of credit management in the distribution channel.

Competitive Threats (New Entrants, Substitutes)

• **China Competition:** A persistent threat, leading to pricing pressure in generic products (Sumitomo, Bayer, Rallis).
• **Generic Competition:** Intense generic competition in India (Bayer) can erode margins for off-patent products.
• **New Entrants:** While barriers to entry are high, new players with innovative technologies or aggressive pricing could pose a threat.
• **Substitutes:** Biologicals and other non-chemical pest control methods could gain traction.

Customer Concentration Risks

• **Crop-specific Dependency:** Companies heavily reliant on a few crops (e.g., Rallis's high dependency on Northern India for cotton) are vulnerable to issues affecting those crops (e.g., declining cotton acreages, illegal varieties).
• **Geographic Concentration:** While companies are diversifying exports, over-reliance on a single export market could be risky.

G. CAPITAL ALLOCATION & INVESTOR RETURNS

Strategic capital allocation is crucial for driving growth, maintaining competitiveness, and delivering investor returns in the agrochemical sector. Companies are balancing investments in capacity expansion, R&D, and working capital management.

Capex Trends and Requirements (Growth vs Maintenance)

The sector is witnessing significant capital expenditure, primarily driven by growth initiatives, particularly in manufacturing and backward integration. * **Sumitomo Chemical India:** Has substantial growth capex plans. It expects to spend **INR 500 crores to INR 600 crores over the next 5 years for 7 products at its Dahej greenfield expansion**. This facility is initially more exports-focused but can cater to domestic demand. Additionally, **INR 8 crores to INR 10 crores will be invested at the Tarapur site** to manufacture Excalia Max for Indian requirements by March 2027, with a mix of exports and domestic utilization. These investments are clearly for expanding capacity and backward integration for new and existing molecules. * **Sharda Cropchem Limited:** Incurred **Rs. 250 Cr in CAPEX in H1 FY26**. While operating an asset-light model for manufacturing, this capex likely supports its forward integration strategy (building sales force, strengthening distribution), product registrations, or other growth-enabling infrastructure. * **Rallis India Limited:** Envisages **capex spends of around INR 50 crores**. This appears to be a more moderate level of capital expenditure, potentially focused on maintenance, smaller upgrades, or specific R&D infrastructure, rather than large-scale greenfield manufacturing expansion. * **Dhanuka Agritech Limited:** Has a synthesis plant at Dahej, which is starting trial production of a second product. This implies ongoing capital investment in manufacturing capabilities, though specific capex figures for the period are not provided.

The trend indicates that companies with in-house manufacturing are investing heavily to enhance their production capabilities, reduce reliance on external sourcing, and support their innovation pipelines.

R&D Investment Levels as % of Revenue

While specific percentages of revenue allocated to R&D are not consistently provided, the absolute figures and strategic emphasis highlight its importance. * **Rallis India Limited:** Allocates **INR 60 crores to INR 70 crores per year for R&D**. This is a significant investment for a company with annual revenues around INR 2000 crores, suggesting an R&D intensity of approximately 3-3.5% of revenue. * **Sumitomo Chemical India:** Has 3 fully equipped, DSIR approved R&D labs and a team of 75+ engineers & scientists, including 10+ PhDs. They have 25+ patents granted and 9 applications filed. While no specific budget is given, the infrastructure and output suggest substantial R&D investment. * **Dhanuka Agritech Limited:** Operates 2 world-class, NABL accredited R&D laboratories and an R&D Lab with 30 chemists at Dahej. Its "Innovation Turnover Index" (new molecules as % of revenue) consistently increasing (16.14% in H1 FY26) is a testament to its R&D effectiveness.

The emphasis on R&D is a critical capital allocation strategy, driving new product development, process improvements, and long-term competitive advantage.

Dividend Policies and Payout Ratios

• **Bayer CropScience Limited:** Declared a **dividend of Rs. 90 per share for H1 FY26**. This indicates a shareholder-friendly policy, returning a portion of profits to investors.
• Dividend policies for other companies are not explicitly detailed in the provided extracts.

Share Buyback Programs

No information regarding share buyback programs is mentioned in the provided data for any of the companies.

M&A Activity and Strategy

The provided data does not indicate any significant M&A activity or specific M&A strategies for the companies. The focus appears to be on organic growth, strategic alliances, and internal investments.

Cash Generation and Free Cash Flow Profiles

Strong cash generation and healthy free cash flow are evident across several players, enabling them to fund capex, manage working capital, and return capital to shareholders. * **Sumitomo Chemical India:** Boasts **Cash and Cash Equivalents of INR 2,089 crores as of 30th September 2025**, describing its liquidity and balance sheet flexibility as "strongest in Indian agrochemical industry." Collections in H1 FY26 were INR 2,277 crores, significantly higher than H1 FY25. * **Sharda Cropchem Limited:** Reported **Cash, Bank & Liquid Investments of Rs. 794 crores as of 30th September 2025** (up from Rs. 558 crores on Mar'25), indicating robust cash generation. * **Rallis India Limited:** Held a **Cash and liquid balance of INR 454 crores as of 30th September 2025**.

These figures demonstrate the sector's ability to generate substantial cash, providing financial resilience and the capacity for future investments.

Capital Efficiency Improvements

Companies are actively working on improving capital efficiency, primarily through better working capital management and optimizing asset utilization. * **Working Capital Efficacy:** Sumitomo's Net Working Capital Days improved by 7 days YoY to 55 days in H1 FY26. Sharda reduced its Working Capital Days by 34 days to 84 days. These improvements directly enhance capital efficiency by reducing the amount of capital tied up in operations. * **ROCE & ROE:** Sharda's significant improvement in ROCE (from 16.0% in FY25 to 21.6% TTM Sep-25) and RoE (from 12.8% to 17.5%) reflects enhanced capital efficiency and profitability. Sumitomo's high ROCE of 29.0% also underscores its efficient use of capital. * **Operational Efficiencies:** Sharda's focus on "operational efficiencies" and "better cost management" contributes to improved capital utilization.

These efforts are critical for maximizing returns on invested capital and ensuring sustainable growth.

H. FUTURE OUTLOOK & PROJECTIONS

The future outlook for the agrochemical sector is characterized by cautious optimism, driven by global stabilization, strong domestic agricultural fundamentals, and a relentless pursuit of innovation and market expansion.

Industry Growth Projections (with timeframes)

• **Global Market:** The global crop protection market is projected to grow at a **CAGR of 3.96% from FY24 to FY33e**, reaching USD 141.7 billion by 2033. This indicates a steady, long-term growth trajectory.
• **Global Stabilization:** The global agrochemical industry is witnessing **early signs of stabilization in 2025** after two years of inventory destocking, pricing pressure, and climate disruptions (Sumitomo, Rallis). This suggests a gradual improvement in demand and stable pricing.
• **Indian Market:**

Management Guidance Across Companies

• **Sumitomo Chemical India Limited:**
• **Bayer CropScience Limited:**
• **Sharda Cropchem Limited:**
• **Dhanuka Agritech Limited:**
• **Rallis India Limited:**

Emerging Opportunities and Whitespace

• **Direct Seeded Rice (DSR):** A significant and growing opportunity driven by labor shortage and sustainability, with Bayer actively expanding its footprint.
• **Specialty and Innovative Products:** Continued focus on new molecule launches and differentiated products (9(3) products) offers higher margin potential and market share gains.
• **Export Market Expansion:** Broadening global footprint, especially in Africa, Latin America, Southeast Asia, and leveraging India as a manufacturing hub for global supply chains.
• **Bio-stimulants and Soil Health:** Regulatory clarity in this segment is expected to benefit organized players, creating a structured growth opportunity.
• **Digital Agriculture:** Leveraging digital platforms for farmer connect, advisory services, and demand creation offers a scalable way to increase penetration and efficiency.
• **Backward Integration:** Opportunities to enhance cost competitiveness and supply security by indigenously manufacturing key active ingredients and intermediates.

Transformation Themes and Inflection Points

• **Shift to Specialty/Branded:** A clear trend towards higher-margin specialty and branded products, moving away from pure generics.
• **Digital Transformation:** Increasing adoption of digital tools for farmer engagement, supply chain management, and market intelligence.
• **Sustainability Focus:** Growing emphasis on sustainable agricultural practices and eco-friendly products, influencing R&D and product portfolios.
• **Supply Chain Resilience:** Regionalization of supply chains and backward integration to mitigate global risks and enhance self-reliance.
• **Policy Support:** Potential policy reconsideration for Indian farmers' access to advanced technologies (e.g., GMO) could be an inflection point for certain segments.

Long-term Structural Trends (5-10 year view)

• **Population Growth & Food Security:** Global population projected to rise to 9.8 billion by 2050 (Sharda), fueling sustained demand for increased food and protein production.
• **Decreasing Arable Land:** Fewer arable acres per capita means products need to maximize farmer yields (Sharda), driving demand for efficient crop protection and yield-enhancing solutions.
• **Changing Dietary Habits:** Growing middle class and demand for diverse food baskets (e.g., non-veg food, milk production driving corn demand for feed) will continue to shape agricultural patterns.
• **Climate Change Adaptation:** Need for climate-resilient crops and agrochemical solutions to mitigate the impact of unpredictable weather patterns.
• **Technological Advancements:** Continuous innovation in crop science, biotechnology, and precision agriculture will drive the evolution of the industry.

Potential Disruptions on the Horizon

• **Rapid Adoption of Biologicals:** If biological solutions become highly effective and cost-competitive, they could disrupt traditional chemical agrochemicals.
• **Breakthroughs in Gene Editing/Biotechnology:** New crop varieties with inherent pest/disease resistance could reduce the need for certain agrochemicals.
• **Aggressive Regulatory Shifts:** Sudden and stringent bans on certain chemistries without viable alternatives could impact product portfolios.
• **Escalating Geopolitical Tensions:** Could lead to significant disruptions in global supply chains and trade flows.

Expected Margin Evolution

• **Overall Improvement:** Bayer expects steady improvement in profitability and 100 bps gross margin expansion. Sharda expects gross margins to remain at 34.5% levels. Sumitomo aims to maintain or improve EBITDA margins.
• **Specialty vs. Generic:** The shift towards specialty products and backward integration is expected to support margin expansion for companies pursuing these strategies.
• **Cost Management:** Continued focus on operational efficiencies and stable input prices will be crucial for margin sustenance.
• **Competitive Pressure:** Intense competition, particularly in generics and exports, might cap margin expansion in certain segments.

In conclusion, while the agrochemical sector faces immediate challenges from climatic variability and competitive pressures, the long-term outlook remains positive, underpinned by fundamental demand drivers and strategic investments in innovation, efficiency, and market expansion. Companies that successfully navigate these complexities through robust R&D, diversified portfolios, efficient operations, and strong farmer relationships are well-positioned for sustainable growth.

I. COMPANY-BY-COMPANY PROFILES

This section provides a detailed profile for each of the major agrochemical companies analyzed, summarizing their financial performance, strategic priorities, competitive advantages, and future outlook.

Sumitomo Chemical India Limited

**Brief Description:** Sumitomo Chemical India Limited is a leading player in the Indian agrochemical industry, benefiting from its strong parentage, Sumitomo Chemical Japan. It is engaged in the manufacturing, formulation, and marketing of crop protection products, environmental health products, and animal nutrition products. The company focuses on both generic and specialty segments, with a strong emphasis on innovation and backward integration.

**Scale Metrics:** * **Consolidated Revenue (H1 FY26):** INR 1,987 crores (+9% YoY) * **Consolidated Revenue (Q2 FY26):** INR 930 crores (-6% YoY) * **Total Assets (as of Sep 30, 2025):** INR 4,438.5 crores * **Manufacturing Facilities:** 5 (Bhavnagar, Gajod, Tarapur, Vapi, Silvassa) * **Technical Actives:** 14 * **Brands:** 200+ (including 20+ mega brands) * **Registrations:** 200+ * **Patents:** 25+ granted, 9 applications filed * **Distribution Network:** 15,000+ Direct Distributors, 60 Depots, covering 26 States * **Farmer Connect:** 4.4 million+ physical, 20 million+ digital * **Employees:** 1600+

**Financial Performance Summary:** * **H1 FY26:** Revenue +9% YoY, Gross Profit +7% YoY, EBITDA +8% YoY, PAT +11% YoY. Margins: Gross Profit Margin 40.4%, EBITDA Margin 22.0%, PAT Margin 17.9%. * **Q2 FY26:** Revenue -6% YoY, Gross Profit -5% YoY, EBITDA -11% YoY, PAT -8% YoY. Margins: Gross Profit Margin 43.1%, EBITDA Margin 23.4%, PAT Margin 19.1%. * **FY20-FY25 CAGR:** Revenue +13%, EBITDA +14%, PAT +20%, Networth +19%. * **ROCE (FY25):** 29.0%. * **Net Working Capital Days (H1 FY26):** 55 days (improved by 7 days YoY). * **Cash and Cash Equivalents (as of Sep 30, 2025):** INR 2,089 crores.

**Strategic Priorities and Focus Areas:** 1. **Strengthening Domestic Franchise & Farmer Engagements:** 'Every Day Farmers Day' (EDFD) initiative, expanding coverage, focusing on Rabi, digital and physical initiatives. 2. **Scaling Up Recently Launched & Differentiated Products:** Lentigo (rice herbicide), Excalia Max (fungicide), Top Grain (H2 FY26 launch). New products contribute 8-10% of yearly revenue. 3. **Enhancing Exports Competitiveness & Global Footprint:** Broadening presence in Africa, Latin America, Southeast Asia. Increasing integration with parent's global supply chain. India as a critical manufacturing and export base. 4. **Advancing Manufacturing & Backward Integration:** Commenced backward integration at Tarapur. Greenfield expansion at Dahej (INR 500-600 Cr capex over 5 years for 7 products) for Sumitomo origin molecules and intermediates. 5. **Sustaining Financial Discipline & Working Capital Efficacy:** Prioritizing liquidity, cash generation, prudent working capital deployment. 6. **R&D Focus:** 3 R&D labs, 75+ scientists, 25+ patents. India identified as #1 category for testing new molecules by Sumitomo Chemical Japan.

**Competitive Advantages and Positioning:** * **Strong Parentage:** Access to global R&D, supply chain, and new molecules from Sumitomo Chemical Japan. * **Financial Strength:** Strongest liquidity and balance sheet in the Indian agrochemical industry. * **Innovation-led Portfolio:** Focus on high-margin specialty products and new launches. * **Backward Integration:** Enhances cost competitiveness and supply security. * **Extensive Reach:** Deep farmer connect and wide distribution network.

**Key Metrics and KPIs Specific to the Company:** * Revenue Mix (H1 FY26): Domestic 85% (grew 11%), Export 15% (degrew 4%). * Product Mix (H1 FY26): Insecticide 39%, Herbicide 26%, PGR 9%, Fungicide 9%, Metal Phosphides 8%, AND & EHD 9%. * Segment Mix: Generic 70%, Specialty 30%. Domestic Bulk 20%, Branded 80%. Export Bulk 34%, Branded 66%. * Technical plants capacity utilization: 85-90%.

**Management Outlook and Guidance:** * Expects recovery in demand during Rabi season and beyond. * Expects to grow more than the industry. * Primary aim: maintain or improve margins (EBITDA, PBT), then top line. Prices are sustainable. * Outlook for exports in H2 is positive.

**Recent Developments and Initiatives:** * Launched Excalia Max (fungicide) and Lentigo (rice herbicide) pan-India. * Commenced backward integration at Tarapur. * Significant progress in project planning for greenfield expansion at Dahej. * Monitoring semiconductor business opportunities in India.

Bayer CropScience Limited

**Brief Description:** Bayer CropScience Limited is the Indian subsidiary of the global life sciences company Bayer AG. It is a leading player in crop protection, seeds (especially corn), and environmental science, focused on innovation and sustainability to address global challenges of food security.

**Scale Metrics:** * **Sales (H1 FY26):** Grew 3% YoY. * **Revenue Growth (Last 5 years ending FY25):** 6.5% CAGR. * **Corn Portfolio Growth (Last 5 years):** Nearly doubled (15-16% CAGR). * **Market Position:** Main breeders for corn in India. India is within the top 5 or 6 countries globally for Crop Science.

**Financial Performance Summary:** * **H1 FY26:** Sales grew 3% YoY (primarily due to corn). Gross Margin expanded by >100 bps. PBT expanded by 6% YoY, PAT expanded by nearly 12.5% YoY. * **FY25:** PAT/EPS saw a significant correction to INR 126 per share. * **Dividend:** Rs. 90 per share for H1 FY26.

**Strategic Priorities and Focus Areas:** 1. **Strengthening the Foundation:** Working on margin framework. 2. **Portfolio Prioritization:** Focus on profitable products and R&D pipeline. 3. **New Launches:** Bicota (fungicide), Camalus (fungicide), Etcio Star (for DSR), Xivana Smart (fruit/veg), Plenexos (global blockbuster insecticide). 4. **Product Supply:** Sourcing more in Asia, more in India (own plants or partners). Backward integrated for larger compounds in India. 5. **Go-to-Market Strategies:** Analyzing Field Officer Territories (FOTs), focusing manpower in profitable areas, leveraging partners and digital. 6. **Cash Management:** Vigilant at managing channel, learned from receivables issues. 7. **Corn Business Acceleration:** Expects to double corn still, accelerating portfolio quickly. 8. **Direct Seeded Rice (DSR):** Actively promoting and expanding DSR acreage. 9. **Better Life Farming:** Partner-based retail ecosystem for farmer service. 10. **OPEX Reduction:** Reduced management layers, go-to-market changes.

**Competitive Advantages and Positioning:** * **Global R&D & Innovation:** Access to a strong global pipeline of new molecules and technologies. * **Corn Leadership:** Dominant position in the high-growth corn seeds segment. * **Strong Brand & Domain Equity:** Recognized brand and strong relationships with regulators. * **Sustainability Focus:** Solutions for productivity gaps and sustainable farming (e.g., DSR).

**Key Metrics and KPIs Specific to the Company:** * Corn portfolio: Double-digit growth in H1 FY26. * Council Activ (fungicide): Among top two/three products. * New products: Almost one-sixth of last year's CP sales from products launched in last three years. * DSR acreage: From 5,000 to 20,000-25,000, targeting over 1 lakh. * Price increase: Nearly double-digit for Dekalb corn products in H1 FY26.

**Management Outlook and Guidance:** * **Next 3-5 year strategic framework (aspirational target):** High single-digit to low double-digit revenue growth, steady improvement in profitability, 100 bps Gross Margin improvement for 2-3 years. * Expects to close FY26 better than FY25 in terms of margins. * FY26 growth: looking to mid-single digits. * Aim to come to a 50-50 situation for India/Asia sourcing vs global sourcing for CP raw materials.

**Recent Developments and Initiatives:** * Launched Bicota and Camalus fungicides. * Expanding DSR program significantly. * Implemented OPEX reduction initiatives.

Sharda Cropchem Limited

**Brief Description:** Sharda Cropchem Limited is a fast-growing global agrochemicals company with a peer position in generic crop protection chemicals. It operates on an asset-light business model, focusing on identifying generic molecules, preparing dossiers, obtaining registrations, and marketing products globally through a widespread distribution network.

**Scale Metrics:** * **Revenue from Operations (H1 FY26):** INR 1,913.9 crores (+23% YoY) * **Revenue from Operations (Q2 FY26):** INR 929.1 crores (+20% YoY) * **Total Equity (as of Sep 30, 2025):** Rs. 2,676 crores * **Registrations:** Procured 2,994, filed 1,068 pending globally. * **Global Presence:** Business operations in 80+ countries. * **Distribution Network:** 525 third-party distributors, 500+ sales force.

**Financial Performance Summary:** * **H1 FY26:** Revenue +23% YoY (volume growth 24%). Gross Profit +51% YoY, EBITDA +69% YoY, PAT +212% YoY. Margins: Gross Profit Margin 35.0%, EBITDA Margin 14.7%, PAT Margin 11.3%. * **Q2 FY26:** Revenue +20% YoY (Agrochem +27%). Gross Profit +49% YoY, EBITDA +71% YoY, PAT +75% YoY. Margins: Gross Profit Margin 34.5%, EBITDA Margin 15.0%, PAT Margin 8.0%. * **FY25:** Revenue INR 4,320 Cr. EBITDA Margin 15.8%, PAT Margin 7.0%. * **ROCE (TTM Sep 30, 2025):** 21.6% (vs 16.0% in FY25). * **RoE (TTM Sep 30, 2025):** 17.5% (vs 12.8% in FY25). * **Working Capital (in Days, Sep 2025):** 84 days (reduced by 34 days from Mar'25). * **Cash, Bank & Liquid Investments (as of Sep 30, 2025):** Rs. 794 crores. * **CAPEX incurred in H1 FY26:** Rs. 250 Cr.

**Strategic Priorities and Focus Areas:** 1. **Forward Integration - Build Sales Force:** Leverage market presence, adopt factory-to-farmer approach. 2. **Expand & Strengthen Distribution Presence:** Penetrate existing markets and enter new ones using existing dossier library. 3. **Continual Investment in Product Registrations:** Identify generic molecules going off patent, prepare dossiers, seek registrations. 4. **Focus on Operational Efficiencies:** Accelerated focus on revenue-generating investments, margin improvements, better cost management.

**Competitive Advantages and Positioning:** * **Asset-Light Business Model:** Outsourced manufacturing provides flexibility, cost competitiveness, and allows focus on core competency of registrations and marketing. * **Extensive IP Library:** Vast and growing library of dossiers and IPRs enables quick market entry globally. * **Global Reach:** Strong presence in 80+ countries, diversifying revenue streams. * **Operational Efficiency:** Demonstrated ability to significantly improve margins through cost management and efficient working capital.

**Key Metrics and KPIs Specific to the Company:** * Agrochemical Segment Revenue (Q2 FY26): INR 803 Cr (+27%), 86% of total revenue. * Product Mix (Q2 FY26 Agrochem): Herbicides 54%, Insecticides 27%, Fungicides 19%. * Region Mix (Q2 FY26 Agrochem): Europe 58%, NAFTA 27%, LATAM 9%, RoW 6%. * Volume growth: 24% in H1 FY26.

**Management Outlook and Guidance:** * Gross Margins expected to remain at 34.5% levels in FY26. * Revenue in H1 FY26 increased by 23% primarily driven by higher volume growth of 24%.

**Recent Developments and Initiatives:** * Significant margin expansion in H1 FY26 due to lower input costs and improved price realizations. * Reduced working capital days substantially.

Dhanuka Agritech Limited

**Brief Description:** Dhanuka Agritech Limited is a leading Indian agrochemical company with a pan-India presence, known for its focus on novel chemistries, extensive product development, and strong international collaborations. It aims for profitable growth through a portfolio of specialty products.

**Scale Metrics:** * **Revenue from Operations (FY25):** INR 2035.15 Crores (+15.7% YoY) * **Revenue from Operations (Q2 FY26):** INR 598.25 Crores (-8.56% YoY) * **Manufacturing Units:** 4 * **Warehouses:** 41 * **Distribution Network:** 6,500+ distributors, 80,000+ retailers. * **Farmer Reach:** Over 10 million farmers. * **Registrations:** 300+, ~90 Products. * **International Collaborations:** Ten leading global agrochemical companies.

**Financial Performance Summary:** * **Q2 FY26:** Revenue -8.56% YoY. Gross Profit -7.99% YoY, EBITDA -14.32% YoY, PAT -20.04% YoY. Margins: Gross Profit Margin 42.45%, EBITDA Margin 22.85%, PAT Margin 15.71%. * **FY25:** Revenue +15.7% YoY. Gross Profit +18.9% YoY, EBITDA +27.2% YoY, PAT +24.2% YoY. Margins: Gross Profit Margin 40.10%, EBITDA Margin 20.47%, PAT Margin 14.59%. * **Basic EPS (Q2 FY26):** INR 20.85 (-19.28% YoY).

**Strategic Priorities and Focus Areas:** 1. **Novel Chemistries & Product Development:** Focus on margin-accretive "9(3) product" portfolio. 2. **International Collaborations:** Tie-ups for latest technology access (e.g., Ipflufenoquin with Nisso Chemicals). 3. **Manufacturing Expansion:** Synthesis plant at Dahej, trial production of second product. 4. **Farmer Engagement:** Dhanuka Krishi Mitra Meetings, Field Days, Village Meetings, digital connects. 5. **R&D Investment:** 2 NABL accredited R&D labs, 30 chemists.

**Competitive Advantages and Positioning:** * **Innovation Focus:** Strong pipeline of novel chemistries and specialty products. * **Global Tie-ups:** Access to advanced technologies and products from international partners. * **Extensive Pan-India Reach:** Deep penetration into rural markets. * **In-house Synthesis:** Enhances control over product quality and cost.

**Key Metrics and KPIs Specific to the Company:** * Innovation Turnover Index (New Molecules as % of Revenue): 16.14% (H1 FY26). * Revenue Mix (Q2 FY26): Insecticides 46%, Fungicides 29%, Herbicides 9%, Others 16%. * Geography Mix (Q2 FY26): North 30%, South 33%, East 13%, West 24%.

**Management Outlook and Guidance:** * **FY26 Guidance:** Expecting flat growth in Revenue from Operations, EBITDA decline of approx. 100bps. * Expects second product from Dahej Plant to help increase revenue. * Sales of Bifenthrin from Dahej on track.

**Recent Developments and Initiatives:** * Introduced Ipflufenoquin for indigenous manufacture. * Started trial production of a second product from Dahej Plant. * Intensive farmer training and digital engagement activities.

Rallis India Limited

**Brief Description:** Rallis India Limited, a Tata Enterprise, is a leading player in the Indian agrochemical sector, focusing on crop protection, seeds, and soil & plant health solutions. The company emphasizes an integrated value chain from R&D to distribution and is actively expanding its export footprint.

**Scale Metrics:** * **Revenue (H1 FY26):** INR 1,818 crores * **Revenue (Q2 FY26):** INR 861 crores (-7% YoY) * **Manufacturing Facilities:** 5 owned (Akola, Lote, Ankaleshwar, Dahej CZ & SEZ), 9 third-party. * **Distribution Network:** 6,600 Dealers, 95,000 Retailers. * **Farmer Connect:** 8 million+. * **Seed Business:** 1,800 Seed villages, 28,000 Growers. * **Export Customers:** 80+.

**Financial Performance Summary:** * **H1 FY26:** Revenue INR 1,818 Cr, EBITDA INR 303 Cr, PAT INR 197 Cr. * **Q2 FY26:** Revenue -7% YoY (Volume -6%, Price -1%). EBITDA -7% YoY, PAT +4% YoY. Margins: EBITDA Margin 17.9%, PAT Margin 11.8%. * **Export Growth (H1 FY26):** 51% (from INR 207 Cr to INR 312 Cr). * **R&D Budget:** INR 60 crores to INR 70 crores per year. * **Cash and liquid balance (as of Sep 30, 2025):** INR 454 crores. * **Capex spends (envisaged):** Around INR 50 crores.

**Strategic Priorities and Focus Areas:** 1. **New Product Launches:** Deeweed (herbicide), Dodrio (fungicide), and 6 other products YTD. 2. **Portfolio Rationalization:** Sharpening focus across key markets. 3. **Export Business Expansion:** Maximizing volume, driving capacity utilization, expanding customer base, securing registrations with global players. 4. **Seed Business Acceleration:** Accelerating launch pipeline for proprietary research varieties, increasing product demonstrations. Focus on 5 key crops (cotton, maize, millet, mustard, rice). 5. **Long-term Improvement Efforts:** Customer centricity, strategic alliances, farmer reach, digitalization, cost competitiveness, Custom Synthesis Manufacturing (CSM). 6. **R&D Focus:** Very focused, less on GM crops, more on modern breeding tools, securing 9(3) registrations.

**Competitive Advantages and Positioning:** * **Integrated Value Chain:** From R&D to distribution and optimization. * **Strong Seed Portfolio:** Over 80% of seed business from own research, strong cotton hybrids. * **Export Growth Driver:** Diversifying revenue through strong export performance. * **Tata Group Backing:** Provides stability and resources. * **Extensive Network:** Wide distribution and farmer connect.

**Key Metrics and KPIs Specific to the Company:** * Q2 FY26 Segment Performance: Crop Care -3% (Domestic -8%, Export +33%), Seeds -29%. * Soil and Plant Health category: H1 flat (planned for 20% growth). * New products (Deeweed, Dodrio): More than doubled volume YTD. * Cotton hybrid 'Diggaz': Strong performance. * Seed business EBITDA margin target: 23% to 25%.

**Management Outlook and Guidance:** * Believes it should be able to grow better than the industry in the long term. * Expects recovery of normal Soil and Plant Health business. * Expects normal volumes for CSM to resume from Q3 or Q4 onward. * Rabi prospects look slightly better. * Domestic agrochem pricing probably will remain subdued. * Industry growth for H1 likely low to mid-single digit. * Q3 and Q4 outlook positive.

**Recent Developments and Initiatives:** * Launched 8 new products YTD in FY26. * Moved bio-stimulant manufacturing in-house to address regulatory challenges. * Focused R&D, stopped vegetable R&D.

J. TABLES

**Table 1: Consolidated Financial Performance Overview (Q2 FY26 vs Q2 FY25)**

| Metric | Sumitomo Chemical India (Q2 FY26) | Sumitomo Chemical India (Q2 FY25) | Sharda Cropchem (Q2 FY26) | Sharda Cropchem (Q2 FY25) | Dhanuka Agritech (Q2 FY26) | Dhanuka Agritech (Q2 FY25) | Rallis India (Q2 FY26) | Rallis India (Q2 FY25) | | :--------------------- | :-------------------------------- | :-------------------------------- | :------------------------ | :------------------------ | :-------------------------- | :-------------------------- | :--------------------- | :--------------------- | | Revenue (Cr) | 930 | 988 | 929.1 | 776.9 | 598.25 | 654.28 | 861 | 928 | | YoY Growth (%) | -6% | - | +20% | - | -8.56% | - | -7% | - | | Gross Profit (Cr) | 401 | 421 | 320.7 | 214.7 | 253.95 | 276.00 | (Not stated) | (Not stated) | | Gross Margin (%) | 43.1% | 42.6% | 34.5% | 27.6% | 42.45% | 42.18% | (Not stated) | (Not stated) | | EBITDA (Cr) | 218 | 245 | 138.9 | 81.3 | 136.73 | 159.58 | 154 | 166 | | EBITDA Margin (%) | 23.4% | 24.8% | 15.0% | 10.5% | 22.85% | 24.39% | 17.9% | 17.9% | | PBT (Cr) | 237.8 | 259.6 | 85.7 | 45.5 | (Not stated) | (Not stated) | (Not stated) | (Not stated) | | PBT Margin (%) | 25.6% | 26.3% | (Not stated) | (Not stated) | (Not stated) | (Not stated) | (Not stated) | (Not stated) | | PAT (Cr) | 178 | 193 | 74.4 | 42.4 | 93.97 | 117.52 | 102 | 98 | | PAT Margin (%) | 19.1% | 19.5% | 8.0% | 5.5% | 15.71% | 17.96% | 11.8% | 10.6% | | Basic EPS (INR) | (Not stated) | (Not stated) | 8.24 | 4.70 | 20.85 | 25.83 | (Not stated) | (Not stated) |

**Table 2: Consolidated Financial Performance Overview (H1 FY26 vs H1 FY25)**

| Metric | Sumitomo Chemical India (H1 FY26) | Sumitomo Chemical India (H1 FY25) | Sharda Cropchem (H1 FY26) | Sharda Cropchem (H1 FY25) | Bayer CropScience (H1 FY26) | Bayer CropScience (H1 FY25) | Rallis India (H1 FY26) | Rallis India (H1 FY25) | | :--------------------- | :-------------------------------- | :-------------------------------- | :------------------------ | :------------------------ | :-------------------------- | :-------------------------- | :--------------------- | :--------------------- | | Revenue (Cr) | 1,987 | 1,827 | 1,913.9 | 1,562.0 | +3% Sales Growth | - | 1,818 | 1,711 | | YoY Growth (%) | +9% | - | +23% | - | +3% | - | +6.2% | - | | Gross Profit (Cr) | 803 | 747 | 669.9 | 443.6 | (Not stated) | (Not stated) | (Not stated) | (Not stated) | | Gross Margin (%) | 40.4% | 40.9% | 35.0% | 28.4% | >100 bps expansion | - | (Not stated) | (Not stated) | | EBITDA (Cr) | 437 | 406 | 281.1 | 166.7 | (Not stated) | (Not stated) | 303 | 261 | | EBITDA Margin (%) | 22.0% | 22.2% | 14.7% | 10.7% | (Not stated) | (Not stated) | 16.6% | 15.3% | | PBT (Cr) | 478.4 | 430.6 | 254.9 | 76.3 | +6% | - | (Not stated) | (Not stated) | | PBT Margin (%) | 24.1% | 23.6% | (Not stated) | (Not stated) | (Not stated) | (Not stated) | (Not stated) | (Not stated) | | PAT (Cr) | 356 | 319 | 217.2 | 69.7 | +12.5% | - | 197 | 146 | | PAT Margin (%) | 17.9% | 17.5% | 11.3% | 4.5% | (Not stated) | (Not stated) | 10.8% | 8.5% | | Basic EPS (INR) | (Not stated) | (Not stated) | 24.06 | 7.72 | (Not stated) | (Not stated) | (Not stated) | (Not stated) |

**Table 3: Key Financial Performance Indices (FY25 & TTM Sep-25)**

| Metric | Sumitomo Chemical India (FY25) | Sharda Cropchem (FY25) | Sharda Cropchem (TTM Sep-25) | Dhanuka Agritech (FY25) | | :--------------------------- | :----------------------------- | :--------------------- | :--------------------------- | :----------------------- | | Revenue (Cr) | (Not stated) | 4,320 | (Not stated) | 2,035.15 | | EBITDA Margin (%) | (Not stated) | 15.8% | (Not stated) | 20.47% | | PAT Margin (%) | (Not stated) | 7.0% | (Not stated) | 14.59% | | ROCE (%) | 29.0% | 16.0% | 21.6% | (Not stated) | | RoE (%) | (Not stated) | 12.8% | 17.5% | (Not stated) | | Net Working Capital Days | 89 | (Not stated) | 84 | (Not stated) | | Cash, Bank & Liquid Inv (Cr) | (Not stated) | 558 | 794 | (Not stated) |

**Table 4: Revenue Mix by Segment/Product (H1 FY26 / Q2 FY26)**

| Company | Segment/Product | Contribution (%) | Growth (YoY) | | :----------------------- | :------------------- | :--------------- | :----------- | | Sumitomo Chemical India | Domestic Agrochemical| 85% | +11% | | | Export Revenue | 15% | -4% | | | Insecticide | 39% | - | | | Herbicide | 26% | - | | | Plant Growth Regulator| 9% | - | | | Fungicide | 9% | - | | | Metal Phosphides | 8% | - | | | AND & EHD | 9% | - | | Sharda Cropchem (Agrochem) | Herbicides | 54% | +20% | | | Insecticides | 27% | +65% | | | Fungicides | 19% | +7% | | Dhanuka Agritech | Insecticides | 46% | - | | | Fungicides | 29% | - | | | Herbicides | 9% | - | | | Others | 16% | - |

**Table 5: Revenue Mix by Geography (Q2 FY26 Agrochemical Segment)**

| Company | Region | Contribution (%) | Growth (YoY) | | :----------------------- | :----------- | :--------------- | :----------- | | Sharda Cropchem | Europe | 58% | +15% | | | NAFTA Region | 27% | +69% | | | LATAM Region | 9% | +21% | | | RoW | 6% | +21% | | Dhanuka Agritech | North | 30% | - | | | South | 33% | - | | | East | 13% | - | | | West | 24% | - |

**Table 6: Innovation Turnover Index (Dhanuka Agritech - New Molecules as % of Total Revenue)**

| Fiscal Year | Innovation Turnover Index (%) | | :---------- | :---------------------------- | | FY22 | 9.05% | | FY23 | 12.75% | | FY24 | 13.29% | | FY25 | 14.93% | | H1 FY25 | 16.09% | | H1 FY26 | 16.14% |